IGC Pharma, Inc. (IGC)
0.2791
0.00 (0.00%)
USD |
NYAM |
May 20, 16:00
0.285
+0.01
(+2.11%)
After-Hours: 20:00
IGC Pharma Cash from Investing (Quarterly) : -0.17M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NRX Pharmaceuticals, Inc. | -0.213M |
| NeOnc Technologies Holdings, Inc. | 0.00 |
| ANI Pharmaceuticals, Inc. | -11.32M |
| Corcept Therapeutics, Inc. | 4.542M |
| Assertio Holdings, Inc. | 15.11M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.223M |
| Cash from Financing (Quarterly) | 0.71M |
| Free Cash Flow Per Share (Quarterly) | -0.0142 |
| Free Cash Flow to Equity (Quarterly) | -2.177M |
| Free Cash Flow to Firm (Quarterly) | -1.393M |
| Free Cash Flow Yield | -20.75% |